|19 Oct 2016 CT-link 2017 is here: new module for Metabolite Prediction is now available|
The 2017 release of CT-link is now available. It contains a number of improved graphical features from the 2016 version. For example, predicted ADME properties for the molecules are now provided. In addition, structural alerts and off-target pharmacology are now linked to both preclinical and clinical safety endpoints. Finally, it offers a new module to generate metabolites and compare their predicted target profiles with those from the original substrates, so safety liabilities from metabolite formation can be assessed. With all these new features, CT-link is now becoming a reference platform in predictive safety.